These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9019639)

  • 21. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ; Weir MR
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of three trials with quinapril in the treatment of mild-to-moderate hypertension in the Mexican population.
    Alcocer L; Novoa G; Sotres D
    Clin Ther; 1995; 17(3):552-60; discussion 516. PubMed ID: 7585859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
    Gall MA; Rossing P; Skøtt P; Hommel E; Mathiesen ER; Gerdes LU; Lauritzen M; Vølund A; Faergeman O; Beck-Nielsen H
    Am J Hypertens; 1992 May; 5(5 Pt 1):257-65. PubMed ID: 1581012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms.
    Pérez-Castrillón JL; Silva J; Justo I; Sanz A; Martín-Luquero M; Igea R; Escudero P; Pueyo C; Díaz C; Hernández G; Dueñas A
    Am J Hypertens; 2003 Jun; 16(6):453-9. PubMed ID: 12799093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.
    Wang Z; Chen Z; Wang X; Hao G; Ma L; Zhao X; Li Y; Zhang L; Zhu M
    J Hypertens; 2017 Apr; 35(4):886-892. PubMed ID: 27977472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Pittrow D; Bohlscheid V
    Fortschr Med Orig; 2003; 121(1):27-32. PubMed ID: 15117066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
    Cooper-DeHoff RM; Wen S; Beitelshees AL; Zineh I; Gums JG; Turner ST; Gong Y; Hall K; Parekh V; Chapman AB; Boerwinkle E; Johnson JA
    Hypertension; 2010 Jan; 55(1):61-8. PubMed ID: 19917874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol.
    Smilde JG
    Eur J Clin Pharmacol; 1983; 25(5):581-3. PubMed ID: 6363096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies.
    Yener G; Aran S; Bahceci M; Ozdemir K; Gultekin F; Lowe W
    Clin Drug Investig; 2007; 27(9):613-22. PubMed ID: 17705570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. Report from a double-blind international multicenter study.
    Wikstrand J; Westergren G; Berglund G; Bracchetti D; Van Couter A; Feldstein CA; Ming KS; Kuramoto K; Landahl S; Meaney E
    JAMA; 1986 Mar; 255(10):1304-10. PubMed ID: 3511308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E; Capurso A; Crepaldi G
    J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.